In addition to the activation of p53 caused by phosphorylation that suppresses the initiation and progression of CRC (Wang et al. 2019), inactivation of p53 by altering p53 regulators or mutations in p53 also occur frequently in CRC (Huang et al. 2018; Zhou et al. 2019). Here, TP53 is linked to colorectal carcinoma.